+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gasmotin"

Gasmotin - API Insight, 2022 - Product Thumbnail Image

Gasmotin - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Gasmotin- Drug Insight, 2019 - Product Thumbnail Image

Gasmotin- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Gasmotin market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat diseases and disorders of the digestive system. Gasmotin is a brand of drug used to treat symptoms of irritable bowel syndrome (IBS) and other gastrointestinal conditions. It works by blocking the action of certain chemicals in the body that cause pain and inflammation. Gasmotin is available in both oral and topical forms, and is often prescribed in combination with other medications. Gasmotin is a popular choice for treating IBS due to its effectiveness and relatively low side effects. It is also used to treat other gastrointestinal conditions such as Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Some companies in the Gasmotin market include GlaxoSmithKline, Pfizer, Merck, and Novartis. Show Less Read more